Duragesic “Black Box” Should Include Pediatric Death Warning – Cmte.
Executive Summary
Enhanced Duragesic "black box" warnings on pediatric deaths are recommended by FDA's Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee
You may also be interested in...
Duragesic Risk Management Plan Under “Discussion”; New Warnings Added
Johnson & Johnson/Alza and FDA are discussing the creation of a risk management program for Duragesic, the agency said in a Feb. 4 letter approving labeling changes for the fentanyl transdermal system
Duragesic Risk Management Plan Under “Discussion”; New Warnings Added
Johnson & Johnson/Alza and FDA are discussing the creation of a risk management program for Duragesic, the agency said in a Feb. 4 letter approving labeling changes for the fentanyl transdermal system
SSRIs And Suicide To Be Discussed By Pediatric Advisory Cmte. In September
FDA's Pediatric Advisory Committee will hold its first meeting in September as a joint session with the Psychopharmacologic Advisory Committee